TPWA
ETON icon

Twin Peaks Wealth Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38
Closed -$938 – 852
2026
Q1 		$938 Buy
+38
New +$664 ﹤0.01% 1914

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Twin Peaks Wealth Advisors's ETON Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Eton Pharmaceutcials (ETON) in Q2 2026, closing a stake of 38 shares — an estimated $938 sold.

Twin Peaks Wealth Advisors first reported a position in ETON in Q1 2026 and held it in 1 quarter. The position peaked at $938 in Q1 2026. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Eton Pharmaceutcials position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 38 Eton Pharmaceutcials shares in Q2 2026, an estimated $938.
  • Twin Peaks Wealth Advisors first reported a position in Eton Pharmaceutcials in Q1 2026 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Eton Pharmaceutcials position peaked at $938 in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.